EMED & Medtronic: The Medical Technology Blueprint Behind the Minneapolis Mystery
Daniel Brooks | Minneapolis Bureau
Minneapolis. Late evening. A confidential medical technology proposal reaches the executive suite. Intellectual property, manufacturing rights, and global distribution dominate the discussions.
The technical evaluation is complete. The financial decision remains unresolved. Stay tuned.
Continue Your Research
Browse the Stock Ratings Directory
Explore Buyout Watch
Visit the Trading Academy
Browse Biotech Catalyst Watch
Browse OTC Buzz Tracker